Neoantigen Targetability in Progressive Advanced Melanoma.

van den Bulk, Jitske; Verdegaal, Els M E; van der Ploeg, Manon; Visser, Marten; Nunes, Joana B; de Ru, Arnoud H; Tjokrodirijo, Rayman T N; Ijsselsteijn, Marieke E; Janssen, Natasja I; van der Breggen, Ruud; de Bruin, Linda; de Kok, Pita; Janssen, George M C; Ruano, Dina; Kapiteijn, Ellen H W; van Veelen, Peter A; de Miranda, Noel F C C; van der Burg, Sjoerd H

van den Bulk, Jitske; Verdegaal, Els M E; van der Ploeg, Manon; Visser, Marten; Nunes, Joana B; de Ru, Arnoud H; Tjokrodirijo, Rayman T N; Ijsselsteijn, Marieke E; Janssen, Natasja I; van der Breggen, Ruud; de Bruin, Linda; de Kok, Pita; Janssen, George M C; Ruano, Dina; Kapiteijn, Ellen H W; van Veelen, Peter A; de Miranda, Noel F C C; van der Burg, Sjoerd H.

Afiliación

van den Bulk J; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
van der Ploeg M; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Visser M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
Nunes JB; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
de Ru AH; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Tjokrodirijo RTN; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Ijsselsteijn ME; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Janssen NI; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
van der Breggen R; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
de Bruin L; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
de Kok P; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
Janssen GMC; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
Ruano D; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Kapiteijn EHW; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
van Veelen PA; Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.

Clin Cancer Res ; 29(20): 4278-4288, 2023 Oct 13.

Article en En | MEDLINE | ID: mdl-37540567

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google